Pacemaker Market Size, Share and Trends Analysis - Global - 2022-2028 - MedCore - Segmented by: Product Type (Single-Chamber, Dual-Chamber, and Leadless Pacemakers)"
The global pacemaker market was valued at $2.5 billion in 2021 and is expected to grow at a CAGR of 2.8% to reach over $3 billion over the forecast period. Our research analyzed pacemaker companies from over 70 countries, providing insights into market size, unit sales, and company market share. We used a comprehensive methodology to ensure accurate projections and provide a comprehensive understanding of the pacemaker market.
The report covers the global market for pacemakers, including single-chamber, dual-chamber, and leadless pacemakers, providing a comprehensive overview of the industry.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
PROCEDURE NUMBERS
The global pacemaker market includes single-chamber, dual-chamber, and leadless pacemaker procedures, both for initial placement and replacement. Despite the decline and recovery in 2020 and 2021 due to delayed and cancelled elective procedures and significant product recalls, the total number of pacemaker procedures is expected to grow at a modest rate over the forecast period.
GLOBAL PACEMAKER MARKET TRENDS
The rise of new technologies in the pacemaker market is driving innovation, but in developed countries, most patients who could benefit from pacemakers already have one implanted. In the coming years, new developments will mainly focus on miniaturization, improved software, wireless connectivity, longer battery life, and MRI-safe devices, which will slow down the pace of price decreases for pacemakers. These advancements will bring new opportunities to the market and improve the patient experience.
GLOBAL PACEMAKER MARKET SHARE INSIGHTS
In the global pacemaker market, Medtronic, Abbott, and Boston Scientific are the top three dominant players. In 2021, Medtronic held the top position in the market with a range of single-chamber, dual-chamber, and leadless pacemakers such as AzureTM, AdvisaTMMRI, AdapatTM, and others. Medtronic has a strong legacy as the pioneering developer of pacemakers and has been a leading manufacturer in the market for a long time. The company's MicraTM line was the first and only available leadless pacemaker on the market until early 2022.
GLOBAL PACEMAKER MARKET SEGMENTATION SUMMARY
Single-chamber pacemakers
Dual-chamber pacemakers
Leadless pacemakers
RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2021
Forecast: 2022-2028
Historical Data: 2018-2021
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only– iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook